{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:56:05Z","timestamp":1776329765100,"version":"3.50.1"},"reference-count":16,"publisher":"Baskent University","issue":"Suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.6002\/ect.mesot2018.o43","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T07:30:09Z","timestamp":1550561409000},"page":"105-109","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of 2 Doses of Rituximab on B-Cell and Antidonor Antibody and Outcomes of ABO-Incompatible Living-Donor Pediatric Kidney Transplant"],"prefix":"10.6002","volume":"17","author":[{"name":"the Department of Nephrology, Toho University, Faculty of Medicine, Tokyo, Japan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Hamasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Itabashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Hyoudou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunobu","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Sakurabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihide","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyo","family":"Oguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichiro","family":"Shishido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4021","reference":[{"key":"ref0","first-page":"18","article-title":"Trends in ABO-incompatible kidney transplantation.","volume":"13","author":"Aikawa","year":"2015","unstructured":"1.\tAikawa A, Saito K, Takahashi K. Trends in ABO-incompatible kidney transplantation. Exp Clin Transplant. 2015;13 Suppl 1:18-22.","journal-title":"Exp Clin Transplant","ISSN":"https:\/\/id.crossref.org\/issn\/1304-0855","issn-type":"print"},{"issue":"5528","key":"ref1","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1136\/bmj.2.5528.1500","article-title":"Fatal pneumococcal septicemia after splenectomy","volume":"2","author":"Karatzas","year":"1966","unstructured":"2.\tKaratzas NB. Fatal pneumococcal septicemia after splenectomy. Br Med J. 1966;2(5528):1500-1501.","journal-title":"Br Med J"},{"issue":"10","key":"ref2","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1111\/j.1600-6143.2005.01031.x","article-title":"ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment","volume":"5","author":"Segev","year":"2005","unstructured":"3.\tSegev DL, Simpkins CE, Warren DS, et al. ABO incompatible high-titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant. 2005;5(10):2570-2575.","journal-title":"Am J Transplant"},{"issue":"6","key":"ref3","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1097\/TP.0000000000001325","article-title":"Immune desensitization allows pediatric blood group incompatible kidney transplantation","volume":"101","author":"Stojanovic","year":"2017","unstructured":"4.\tStojanovic J, Adamusiak A, Kessaris N, et al. Immune desensitization allows pediatric blood group incompatible kidney transplantation. Transplantation. 2017;101(6):1242-1246.","journal-title":"Transplantation"},{"issue":"5","key":"ref4","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1399-3046.2011.01480.x","article-title":"ABO-incompatible kidney transplantation in children","volume":"15","author":"Tyden","year":"2011","unstructured":"5.\tTyden G, Kumlien G, Berg UB. ABO-incompatible kidney transplantation in children. Pediatr Transplant. 2011;15(5):502-504.","journal-title":"Pediatr Transplant"},{"issue":"3","key":"ref5","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/ajt.13502","article-title":"ABO-incompatible living kidney transplants: evolution of outcomes and immunosuppressive management","volume":"16","author":"Okumi","year":"2016","unstructured":"6.\tOkumi M, Toki D, Nozaki T, et al. ABO-incompatible living kidney transplants: evolution of outcomes and immunosuppressive management. Am J Transplant. 2016;16(3):886-896.","journal-title":"Am J Transplant"},{"issue":"2","key":"ref6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.trim.2014.06.001","article-title":"Late-onset neutropenia and acute rejection in ABO-incompatible kidney transplant recipients receiving rituximab and mycophenolate mofetil","volume":"31","author":"Kabei","year":"2014","unstructured":"7.\tKabei K, Uchida J, Iwai T, et al. Late-onset neutropenia and acute rejection in ABO-incompatible kidney transplant recipients receiving rituximab and mycophenolate mofetil. Transpl Immunol. 2014;31(2):92-97.","journal-title":"Transpl Immunol"},{"issue":"10","key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13071","article-title":"Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: Advantages and disadvantages of rituximab pretreatment.","volume":"31","author":"Okada","year":"2017","unstructured":"8.\tOkada M, Watarai Y, Iwasaki K, et al. Favorable results in ABO-incompatible renal transplantation without B cell-targeted therapy: Advantages and disadvantages of rituximab pretreatment. Clin Transplant. 2017;31(10).","journal-title":"Clin Transplant","ISSN":"https:\/\/id.crossref.org\/issn\/0902-0063","issn-type":"print"},{"issue":"6","key":"ref8","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/j.1538-7836.2010.03818.x","article-title":"Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura","volume":"8","author":"McDonald","year":"2010","unstructured":"9.\tMcDonald V, Manns K, Mackie IJ, Machin SJ, Scully MA. Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura. J Thromb Haemost. 2010;8(6):1201-1208.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"ref9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s10157-007-0461-z","article-title":"Recent findings in ABO-incompatible kidney transplantation: classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment of accommodation","volume":"11","author":"Takahashi","year":"2007","unstructured":"10.\tTakahashi K. Recent findings in ABO-incompatible kidney transplantation: classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment of accommodation. Clin Exp Nephrol. 2007;11(2):128-141.","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"ref10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1432-2277.2008.00821.x","article-title":"Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients","volume":"22","author":"Toki","year":"2009","unstructured":"11.\tToki D, Ishida H, Horita S, Setoguchi K, Yamaguchi Y, Tanabe K. Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients. Transpl Int. 2009;22(4):447-454.","journal-title":"Transpl Int"},{"issue":"6","key":"ref11","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1111\/ajt.12220","article-title":"A single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function","volume":"13","author":"Kamburova","year":"2013","unstructured":"12.\tKamburova EG, Koenen HJ, Borgman KJ, ten Berge IJ, Joosten I, Hilbrands LB. A single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function. Am J Transplant. 2013;13(6):1503-1511.","journal-title":"Am J Transplant"},{"issue":"8","key":"ref12","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1097\/TP.0b013e31819e0054","article-title":"Identification and characterization of major proteins carrying ABO blood group antigens in the human kidney","volume":"87","author":"Tasaki","year":"2009","unstructured":"13.\tTasaki M, Yoshida Y, Miyamoto M, et al. Identification and characterization of major proteins carrying ABO blood group antigens in the human kidney. Transplantation. 2009;87(8):1125-1133.","journal-title":"Transplantation"},{"issue":"6","key":"ref13","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/ndt\/gfw017","article-title":"The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation","volume":"31","author":"Lee","year":"2016","unstructured":"14.\tLee J, Lee JG, Kim S, et al. The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation. Nephrol Dial Transplant. 2016;31(6):1013-1021.","journal-title":"Nephrol Dial Transplant"},{"issue":"2-3","key":"ref14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.trim.2013.01.003","article-title":"Late-onset neutropenia (LON) after low-dose rituximab treatment in living related kidney transplantation--single-center study.","volume":"28","author":"Ishida","year":"2013","unstructured":"15.\tIshida H, Inui M, Furusawa M, Tanabe K. Late-onset neutropenia (LON) after low-dose rituximab treatment in living related kidney transplantation--single-center study. Transpl Immunol. 2013;28(2-3):93-99.","journal-title":"Transpl Immunol","ISSN":"https:\/\/id.crossref.org\/issn\/0966-3274","issn-type":"print"},{"issue":"11","key":"ref15","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1097\/TP.0000000000002259","article-title":"Outcomes of pediatric ABO-incompatible living kidney transplantations from 2002 to 2015: An analysis of the Japanese Kidney Transplant Registry","volume":"102","author":"Hattori","year":"2018","unstructured":"16.\tHattori M, Mieno M, Shishido S, et al. Outcomes of pediatric ABO-incompatible living kidney transplantations from 2002 to 2015: An analysis of the Japanese Kidney Transplant Registry. Transplantation. 2018;102(11):1934-1942","journal-title":"Transplantation"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T03:53:51Z","timestamp":1550634831000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/forms\/ectrxcontentshow.php?doi_id=10.6002\/ect.MESOT2018.O43"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":16,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2019,1]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.mesot2018.o43","relation":{},"ISSN":["1304-0855"],"issn-type":[{"value":"1304-0855","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}